Komori
Alfresa Holdings (2784) · FactFirst stated

FY2022-Q1 Medical-Related Business: Revenue Growth and Continued Operating Loss

First written in FY2022-Q1. . Latest entry: FY2022-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Continued Operating Loss Amid Revenue Growth in Medical-Related BusinessA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022-Q1First statedAnnual report

    「当セグメントの当第１四半期連結累計期間の業績は、薬価改定および新型コロナウイルス感染症等の影響により、売上高83億69百万円、営業損失2億72百万円となりました。」

    医療関連事業は売上高が前年同期を上回った一方、営業損失2億72百万円となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.